BCL2 and neoplasm: Treatment of Annonacin (0.5–1 μM) induced MCF breast cancer cell line death at 48 h and treatment of Annonacin (0.1 μM) in xenografts tumor decreases the expression of ER, cyclin D1, and Bcl2 (Figure 5) [135].